MAINO, ELENA
MAINO, ELENA
Combination of eutos score and 3-month bcr-abl transcript level identifies a group of good-risk chronic myeloid leukemia patients with favourable response to frontline imatinib therapy.
2015 Tiribelli, M; Binotto, Gianni; Calistri, E; Maino, Elena; Scaffidi, L; Medeot, M; Nabergoj, Mitja; Ambrosetti, A; Semenzato, GIANPIETRO CARLO; Fanin, R; Bonifacio, M; Gruppo Triveneto, L. M. C.
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia.
2013 Tiribelli, M; Bonifacio, M; Calistri, E; Binotto, Gianni; Maino, Elena; Marin, L; Guardalben, E; Branca, Antonio; Gherlinzoni, F; Semenzato, GIANPIETRO CARLO; Sancetta, R; Pizzolo, G; Fanin, R.
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients
2018 Tiribelli, Mario; Bonifacio, Massimiliano; Binotto, Gianni; Iurlo, Alessandra; Cibien, Francesca; Maino, Elena; Guella, Anna; Festini, Gianluca; Minotto, Claudia; De Biasi, Ercole; De Marchi, Federico; Scaffidi, Luigi; Frison, Luca; Bucelli, Cristina; Medeot, Marta; Calistri, Elisabetta; Sancetta, Rosaria; Stulle, Manuela; Orofino, Nicola; Krampera, Mauro; Gherlinzoni, Filippo; Semenzato, Gianpietro; Pizzolo, Giovanni; Ambrosetti, Achille; Fanin, Renato
Imatinib-treated Chronic Myeloid Leukemia patients with discordant response between cytogenetic and molecular tests at 3 and 6 month time-points have a reduced probability of subsequent optimal response.
2015 Bonifacio, M; Binotto, Gianni; Maino, Elena; Calistri, E; Marin, L; Scaffidi, L; Frison, Luca; De Marchi, F; Krampera, M; Semenzato, GIANPIETRO CARLO; Fanin, R; Ambrosetti, A; Tiribelli, M.